Shin Nippon Biomedical Laboratories Ltd is a Japan-based company engaged in contract research organization (CRO) business, translational research (TR) business, and other businesses. It operates through four business segments. CRO segment includes non-clinical business using laboratory animals, cells, and bacteria to confirm the efficacy and safety of drugs under development by pharmaceutical companies, and clinical business, conducting trials to confirm efficacy and safety in humans. Translational Research segment develops nasal delivery platform technologies and conducts non-clinical and clinical testing necessary for the evaluation and approval of pharmaceuticals and others. Medipolis segment operates accommodation facilities and geothermal power generation businesses. United States Real Estate segment rents out multi-purpose industrial buildings constructed on sites owned by its subsidiary. It also undertakes administrative work and provides support for the group's operations.

• Revenue in JPY (TTM)31.37bn
• Net income in JPY3.99bn
• Incorporated1973
• Employees1.44k

• Location
  Shin Nippon Biomedical Laboratories Ltd28F, St Luke's Tower, 8-1, Akashi-choCHUO-KU 104-0044JapanJPN
• Phone+81 355655001
• Fax+81 355656160
• Websitehttps://snbl.com